Inhibition in proliferation and altered morphology were reversible when ATRA treatment was discontinued [10]
The three mouse models were SAMP-1 female mice with accelerated aging, wild rats, SAMR-1, and SHR (both female mice)
You can see the temporary spike during dose transitions and understand that it will resolve as the new steady state establishes itself over the following weeks
If any apply, the medication should not be prescribed: Personal or family history of medullary thyroid carcinoma (MTC) Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Known serious hypersensitivity to the active medication or to a related incretin-receptor agonist Clinical precautions that prompt careful screening These are not absolute contraindications on the FDA label, but they meaningfully change the risk-benefit conversation
Resistance-Training Use resistance training (weights) to help prevent muscle loss
The glucose-dependent mechanism of action results in a low intrinsic risk of hypoglycemia when used as monotherapy or with metformin, though risk increases when combined with insulin or sulfonylureas